P
Phong Phu Pharmaceutical JSC
VN:PPP
Phong Phu Pharmaceutical JSC
VN:PPP
Price:
19 000
VND
-7.32%
Market Closed
Market Cap:
₫167.2B
Balance Sheet
Balance Sheet Decomposition
Phong Phu Pharmaceutical JSC
Phong Phu Pharmaceutical JSC
Balance Sheet Decomposition is not available for
Phong Phu Pharmaceutical JSC
Phong Phu Pharmaceutical JSC
Balance Sheet
Phong Phu Pharmaceutical JSC
Phong Phu Pharmaceutical JSC
Currency: VND
| Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash & Cash Equivalents |
3 829
|
2 112
|
1 885
|
1 263
|
640
|
6 745
|
1 464
|
5 445
|
10 538
|
14 168
|
6 831
|
12 375
|
9 497
|
9 009
|
12 118
|
10 301
|
8 482
|
8 876
|
9 540
|
|
| Cash |
3 829
|
2 112
|
1 885
|
1 263
|
640
|
6 745
|
1 464
|
5 445
|
3 538
|
14 168
|
6 831
|
12 375
|
9 497
|
5 509
|
6 118
|
6 301
|
4 482
|
4 876
|
4 540
|
|
| Cash Equivalents |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7 000
|
0
|
0
|
0
|
0
|
3 500
|
6 000
|
4 000
|
4 000
|
4 000
|
5 000
|
|
| Short-Term Investments |
15 000
|
13 065
|
4 000
|
4 000
|
450
|
2 000
|
0
|
0
|
0
|
0
|
0
|
0
|
4 500
|
0
|
6 000
|
16 000
|
23 563
|
31 108
|
35 984
|
|
| Total Receivables |
1 648
|
1 648
|
5 683
|
6 635
|
9 759
|
9 734
|
8 362
|
12 751
|
17 738
|
14 480
|
19 763
|
12 849
|
11 987
|
10 608
|
10 768
|
14 181
|
14 580
|
11 998
|
9 430
|
|
| Accounts Receivables |
1 202
|
1 218
|
3 028
|
3 977
|
5 752
|
6 708
|
6 149
|
11 005
|
16 117
|
13 338
|
14 333
|
10 292
|
11 531
|
10 133
|
10 446
|
13 568
|
13 188
|
11 094
|
7 508
|
|
| Other Receivables |
446
|
430
|
2 655
|
2 658
|
4 007
|
3 026
|
2 213
|
1 747
|
1 621
|
1 142
|
5 430
|
2 557
|
456
|
475
|
322
|
613
|
1 392
|
904
|
1 922
|
|
| Inventory |
4 295
|
5 982
|
4 773
|
4 652
|
8 013
|
9 686
|
15 492
|
15 007
|
16 325
|
21 108
|
22 582
|
31 781
|
36 729
|
34 712
|
41 533
|
36 759
|
32 000
|
36 899
|
40 064
|
|
| Other Current Assets |
711
|
265
|
410
|
5 699
|
5 027
|
12 514
|
1 047
|
233
|
395
|
5 023
|
457
|
549
|
695
|
562
|
356
|
1 231
|
1 020
|
2 346
|
1 260
|
|
| Total Current Assets |
25 483
|
23 072
|
16 752
|
22 249
|
23 889
|
40 679
|
26 365
|
42 436
|
44 996
|
54 779
|
49 633
|
57 554
|
63 409
|
54 891
|
70 775
|
78 472
|
79 644
|
91 228
|
96 277
|
|
| PP&E Net |
7 429
|
7 911
|
29 777
|
30 700
|
49 121
|
49 353
|
55 875
|
53 679
|
51 139
|
54 618
|
80 821
|
77 178
|
73 127
|
68 777
|
64 374
|
60 239
|
60 464
|
57 498
|
56 184
|
|
| PP&E Gross |
7 429
|
7 911
|
29 777
|
30 700
|
49 121
|
49 353
|
55 875
|
53 679
|
51 139
|
54 618
|
80 821
|
77 178
|
73 127
|
68 777
|
64 374
|
60 239
|
60 464
|
57 498
|
56 184
|
|
| Accumulated Depreciation |
5 641
|
6 287
|
6 280
|
7 034
|
7 577
|
8 095
|
9 875
|
12 253
|
15 354
|
18 494
|
21 832
|
27 144
|
32 575
|
36 528
|
42 009
|
47 538
|
51 610
|
54 328
|
57 867
|
|
| Intangible Assets |
82
|
15
|
12
|
9
|
6
|
25 249
|
24 647
|
20 720
|
20 161
|
21 538
|
20 942
|
20 994
|
20 334
|
19 638
|
18 941
|
18 244
|
17 548
|
16 851
|
16 171
|
|
| Note Receivable |
380
|
563
|
269
|
352
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
16
|
17
|
17
|
16
|
16
|
55
|
50
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4 100
|
|
| Other Long-Term Assets |
522
|
488
|
459
|
431
|
402
|
1 203
|
2 463
|
2 042
|
1 122
|
780
|
2 266
|
1 705
|
1 058
|
1 336
|
1 923
|
1 222
|
2 350
|
1 510
|
3 937
|
|
| Total Assets |
33 896
N/A
|
32 048
-5%
|
47 269
+47%
|
53 741
+14%
|
73 418
+37%
|
116 483
+59%
|
109 350
-6%
|
118 878
+9%
|
117 419
-1%
|
131 714
+12%
|
153 662
+17%
|
157 447
+2%
|
157 945
+0%
|
144 659
-8%
|
156 030
+8%
|
158 194
+1%
|
160 022
+1%
|
167 142
+4%
|
176 720
+6%
|
|
| Liabilities | ||||||||||||||||||||
| Accounts Payable |
1 085
|
668
|
1 299
|
2 085
|
3 871
|
8 912
|
12 633
|
17 400
|
16 570
|
18 338
|
23 176
|
14 790
|
21 367
|
14 303
|
16 378
|
12 642
|
11 688
|
13 502
|
10 230
|
|
| Accrued Liabilities |
0
|
0
|
0
|
33
|
180
|
255
|
474
|
506
|
1 133
|
709
|
1 300
|
2 942
|
4 593
|
4 920
|
7 455
|
9 255
|
10 760
|
10 836
|
13 859
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
15 267
|
0
|
1 000
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
1 500
|
0
|
0
|
0
|
0
|
0
|
2 865
|
2 865
|
18 560
|
25 281
|
27 397
|
3 562
|
4 703
|
4 436
|
2 000
|
0
|
0
|
0
|
6 287
|
|
| Other Current Liabilities |
1 368
|
443
|
973
|
897
|
652
|
6 894
|
1 686
|
577
|
4 047
|
6 113
|
4 106
|
7 456
|
7 658
|
6 506
|
13 389
|
11 519
|
6 978
|
7 229
|
7 409
|
|
| Total Current Liabilities |
3 953
|
1 111
|
2 272
|
2 949
|
4 704
|
16 062
|
17 659
|
18 484
|
40 311
|
50 441
|
55 979
|
44 018
|
38 320
|
31 165
|
39 222
|
33 417
|
29 426
|
31 567
|
37 785
|
|
| Long-Term Debt |
3 331
|
2 767
|
16 005
|
20 698
|
36 590
|
68 271
|
61 500
|
48 680
|
21 400
|
5 973
|
22 178
|
18 035
|
13 332
|
5 665
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
479
|
419
|
427
|
425
|
1 166
|
1 166
|
1 039
|
1 518
|
1 431
|
1 382
|
823
|
246
|
233
|
233
|
225
|
225
|
225
|
217
|
206
|
|
| Total Liabilities |
7 763
N/A
|
4 296
-45%
|
18 703
+335%
|
24 071
+29%
|
42 460
+76%
|
85 499
+101%
|
80 197
-6%
|
68 681
-14%
|
63 142
-8%
|
57 796
-8%
|
78 980
+37%
|
62 298
-21%
|
51 885
-17%
|
37 063
-29%
|
39 447
+6%
|
33 642
-15%
|
29 651
-12%
|
31 784
+7%
|
37 990
+20%
|
|
| Equity | ||||||||||||||||||||
| Common Stock |
22 000
|
22 000
|
22 000
|
23 355
|
23 355
|
23 355
|
29 800
|
45 000
|
45 000
|
60 000
|
60 000
|
80 000
|
88 000
|
88 000
|
88 000
|
88 000
|
88 000
|
88 000
|
88 000
|
|
| Retained Earnings |
416
|
1 484
|
2 320
|
1 782
|
2 856
|
2 568
|
4 941
|
853
|
4 452
|
8 285
|
8 414
|
8 187
|
9 864
|
10 876
|
19 011
|
25 974
|
30 810
|
34 892
|
37 272
|
|
| Additional Paid In Capital |
2 206
|
2 206
|
2 206
|
2 206
|
2 206
|
2 206
|
2 206
|
2 206
|
2 206
|
2 206
|
2 206
|
2 206
|
2 206
|
2 206
|
2 206
|
2 206
|
2 206
|
2 206
|
2 206
|
|
| Other Equity |
1 511
|
2 062
|
2 039
|
2 328
|
2 542
|
2 856
|
2 088
|
2 139
|
2 620
|
3 428
|
4 062
|
4 756
|
5 990
|
6 514
|
7 367
|
8 373
|
9 355
|
10 261
|
11 252
|
|
| Total Equity |
26 133
N/A
|
27 751
+6%
|
28 565
+3%
|
29 670
+4%
|
30 958
+4%
|
30 984
+0%
|
29 153
-6%
|
50 197
+72%
|
54 277
+8%
|
73 919
+36%
|
74 682
+1%
|
95 149
+27%
|
106 060
+11%
|
107 596
+1%
|
116 583
+8%
|
124 553
+7%
|
130 371
+5%
|
135 358
+4%
|
138 730
+2%
|
|
| Total Liabilities & Equity |
33 896
N/A
|
32 048
-5%
|
47 269
+47%
|
53 741
+14%
|
73 418
+37%
|
116 483
+59%
|
109 350
-6%
|
118 878
+9%
|
117 419
-1%
|
131 714
+12%
|
153 662
+17%
|
157 447
+2%
|
157 945
+0%
|
144 659
-8%
|
156 030
+8%
|
158 194
+1%
|
160 022
+1%
|
167 142
+4%
|
176 720
+6%
|
|
| Shares Outstanding | ||||||||||||||||||||
| Common Shares Outstanding |
2
|
2
|
2
|
2
|
3
|
3
|
3
|
5
|
5
|
7
|
7
|
8
|
9
|
9
|
9
|
9
|
9
|
9
|
9
|
|
Switch to:
Switch to:
See Also
Discover More
